(Updates with the analyst upgrade and stock move in the last two paragraphs.) ADMA Biologics (ADMA) late Wednesday reported a Q3 loss of $0.13 per share,...
Health care stocks were higher ahead of Thursday's market open. The Health Care SPDR (XLV) added 0.1% and the iShares NASDAQ Biotechnology Index (IBB) rose...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Health care stocks were muted ahead of Thursday's market open. The Health Care SPDR (XLV) was up 0.1% and the iShares NASDAQ Biotechnology Index (IBB) was...
| Address | 465 State Route 17 South Ramsey, New Jersey 07446-2012 |
| Phone | +1.201.478.5552 |
| Number of Employees | 318 |
| Recent SEC Filing | 11/16/2021 8-K |
| President, Chief Executive Officer & Director | Adam S. Grossman |
| Chief Financial Officer & Executive Vice President | Brian Lenz |
| Vice President-Compliance & Clinical Operations | Kaitlin Kestenberg |
| Senior Director-Scientific & Data Analysis | Lucy DeMario |
| Price Open | $1.43 |
| Previous Close | $1.38 |
| 52 Week Range | $1.01 - 3.11 |
| Market Capitalization | $270.2 M |
| Shares Outstanding | 195.8 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 03/24/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.65 |
| Beta vs. S&P 500 | N/A |
| Revenue | $17.0 M |
| Net Profit Margin | -108.60% |
| Return on Equity | -71.69% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
